Results 81 to 90 of about 10,218 (198)

Management of device embolization following left atrial appendage closure: Two cases and a review of the literature

Journal of Arrhythmia, Volume 41, Issue 4, August 2025.
Device embolization following left atrial appendage closure occurs in 0.6%–1.5% of cases and represents a rare but serious complication that can be effectively managed through tailored percutaneous retrieval strategies with high procedural success rates when performed by experienced operators. Abstract Objectives Device embolization (DE) following left
Ahmet Kivrak, Ahmet Hakan Ates, Ugur Canpolat, Mert Dogan, Cem Coteli, Hikmet Yorgun, Mehmet Levent Sahiner, Ergun Barıs Kaya, Kudret Aytemir   +8 more
wiley   +1 more source

Andersen-Tawil Syndrome [PDF]

, 2006
Andersen-Tawil syndrome (ATS) is a rare condition consisting of ventricular arrhythmias, periodic paralysis, and dysmorphic features. In 2001, mutations in KCNJ2, which encodes the α subunit of the potassium channel Kir2.1, were identified in patients ...
Fish, Frank A, Kannankeril, Prince J, Smith, Andrew H   +2 more
core   +2 more sources

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. [PDF]

, 2016
Peer ...
Abreu Filho, Adriaan A. Voors, Anders Ahlsson, Antonio Coca, Antonis S. Manolis, Arsenault, Athanasios Manolis, Barbara Casadei, Bart Van Putte, Bogdan Alexandru Popescu, Bonizzi, Bronis, Bulent Gorenek, Clare J. Taylor, Clarkesmith, Cox, Cox, Dan Atar, Davy, de Salle, Dipak Kotecha, Dobromir Dobrev, Donna Fitzsimons, Emdin, Fabritz, Falk, Felmeden, Filip Casselman, Frank Ruschitzka, Friberg, Gerasimos Filippatos, Gerhard Hindricks, Goldberger, Goldstone, Gonzalo Baron Esquivias, Gregory Y. H. Lip, Gutierrez, Haemers, Hans-Christoph Diener, Hart, Hein Heidbuchel, Henry, Hou, Hughes, Irina Savelieva, Isabelle C. Van Gelder, Jensen, Jeroen Hendriks, John Camm, John McMurray, Jonas Oldgren, Jose Luis Zamorano, José M. Ferro, Juan Luis Tamargo, Karjalainen, Katja Zeppenfeld, Kobayashi, Lafuente-Lafuente, Lee, Lewis, Liakopoulos, Loose, Lundstrom, Magee, Manolis, Manuel Castella, Maxine Guenoun, McCabe, Nieuwlaat, Ott, Overvad, Paciaroni, Palareti, Panagiotis Vardas, Paulus Kirchhof, Pepine, Philippe Kolh, Piotr Ponikowski, Piotr Suwalski, Porter, Poulidakis, Raffaele De Caterina, Raphael Rosenhek, Roy, Sanjay Sharma, Savelieva, Scipione Carerj, Senechal, Spiridon Deftereos, Stacey, Stambler, Stefan Agewall, Stefan H. Hohnloser, Stefano Benussi, Stephan Windecker, Stroke Prevention in Atrial Fibrillation Investigators, Stroobandt, Szymanski, Tischenko, Tran, Tschuppert, Ulrich Schotten, Venteclef, Vijayalakshmi, Waldo, Wang, Watanabe, Werner Budts, Whitlock, Wilson   +109 more
core   +5 more sources

Experience with propafenone for the treatment of cardiac arrhythmias in children

The Turkish Journal of Pediatrics, 1990
The aim of this prospective study was to evaluate the efficacy of propafenone in suppressing various arrhythmias in a group of children who were patients in the Pediatric Cardiology Unit of Hacettepe University Children's Hospital. Seven of the 13
A Celiker, S Ozer, S Ozme, S Ozkutlu, O Kahramanyol   +4 more
doaj  

Propafenone efficacy in treatment of atrial fibrillation paroxysms: a placebo-controlled study

Российский кардиологический журнал, 2005
In a placebo-controlled study, propafenone efficacy and safety for pharmaceutical cardioversion in atrial fibrillation (AF) paroxysms were studied. The study included 50 patients aged 28-69 years (mean age 53,9+9,7), with AF paroxysms lasting for less ...
Yu. A. Bunin, L. K. Anfalova
doaj  

ω-3 and ω-6 polyunsaturated fatty acids block HERG channels [PDF]

, 2005
11 pages, 7 figures.Dietary polyunsaturated fatty acids (PUFAs) have been reported to exhibit antiarrhythmic properties, which have been attributed to their availability to modulate Na(+), Ca(2+), and several K(+) channels.
Arias, Cristina, David, Miren, González, Teresa, Guizy, Miriam, Valenzuela, Carmen   +4 more
core   +2 more sources

Propafenone analogue with additional H‐bond acceptor group shows increased inhibitory activity on P‐glycoprotein [PDF]

, 2020
Anna Cseke, Theresa Schwarz, Sankalp Jain, Simon Decker, Kerstin Vogl, Ernst Urban, Gerhard F. Ecker   +6 more
openalex   +1 more source

Prevention of atrial fibrillation episodes in patients with chronic heart failure: a new approach to the old problem

Кардиоваскулярная терапия и профилактика, 1970
Aim. To study clinical effectiveness and safety of propafenone and amiodarone in patients with arterial hypertension (AH), coronary heart disease (CHD), chronic heart failure (CHF) with preserved left ventricular (LV) systolic function, and atrial ...
Yu. M. Pozdnyakov, O. N. Miller, S. A. Luchinsky, V. L. Doshchitsyn   +3 more
doaj  

Frequency Analysis of Atrial Fibrillation From the Surface Electrocardiogram [PDF]

, 2004
Atrial fibrillation (AF) is the most common arrhythmia encountered in clinical practice. Neither the natural history of AF nor its response to therapy are sufficiently predictable by clinical and echocardiographic parameters.
Bollmann, Andreas, Husser, Daniela, Olsson, Bertil, Sornmo, Leif, Stridh, Martin   +4 more
core  

Arrhythmic risk in elderly patients candidates to transcatheter aortic valve replacement. predicative role of repolarization temporal dispersion [PDF]

, 2019
Degenerative aortic valve stenosis (AS) is associated to ventricular arrhythmias and sudden cardiac death, as well as mental stress in specific patients. In such a context, substrate, autonomic imbalance as well as repolarization dispersion abnormalities ...
Crapanzano, Davide, DI IORIO, Claudia, Fabietti, Marcella, Magri', Damiano, Mariani, MARCO VALERIO, Mastropietri, Fabiola, Moscucci, Federica, Parrotta, Ilaria, Piccirillo, Gianfranco, Sabatino, Teresa, Salvi, Nicolo', Vespignani, Giulia   +11 more
core   +1 more source